Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2005
09/21/2005EP1575993A2 Methods for treating patients and identifying therapeutics
09/21/2005EP1575916A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
09/21/2005EP1575673A2 Use of a trpm8-activating substance for the treatment of tumours
09/21/2005EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders
09/21/2005EP1575618A2 Dispersible pharmaceutical compositions
09/21/2005EP1575598A1 Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
09/21/2005EP1575594A2 Combination of reboxetine and a cyclooxygenase-2 inhibitor
09/21/2005EP1575590A1 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
09/21/2005EP1575583A1 Treatment of hiv infection through combined administration of tipranavir and capravirine
09/21/2005EP1575582A1 Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
09/21/2005EP1575580A2 Method of treating cancers
09/21/2005EP1575579A2 Compositions comprising a combination of diphenyl urea impdh inhibitors and apoptosis-inducing anti-cancer agents
09/21/2005EP1575576A2 Organic compounds
09/21/2005EP1575573A2 Agents and methods for treatment of disease by oligosaccharide targeting agents
09/21/2005EP1575567A1 Method and reagents for treating or preventing atherosclerosis and diseases associated therewith
09/21/2005EP1575566A1 Multilayer dosage forms containing nsaids and triptans
09/21/2005EP1575558A2 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium
09/21/2005EP1575549A2 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid
09/21/2005EP1575533A2 Topical compositions having a natural ingredient and method of use
09/21/2005EP1575528A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575519A2 Cd26-based therapies for cancers and immune disease
09/21/2005EP1575504A2 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575479A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
09/21/2005EP1575379A1 Nutritional compositions
09/21/2005EP1438038A4 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
09/21/2005EP1435965A4 Pharmaceutical compositions and methods for treating cancer
09/21/2005EP1420790B1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
09/21/2005EP1401463B1 Compositions comprising thylakoids useful in the modulation of the inflammation process
09/21/2005EP1299382B1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005EP1263446B1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
09/21/2005EP1129188B1 Pge synthase and methods and means for modulating its activity
09/21/2005EP1002065B1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations
09/21/2005EP0996459B1 Use of exendins and agonists thereof for the reduction of food intake
09/21/2005CN1671742A Use of HMGB1 in the treatment of tissue damage and/or to promote tissue repair
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671661A Aromatic sulfones and their medical use
09/21/2005CN1671435A Medicament dispenser
09/21/2005CN1671421A Inclusion complexes of rosiglitazone
09/21/2005CN1671415A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
09/21/2005CN1671414A CpG formulations and related methods
09/21/2005CN1671412A Immunostimulatory compositions and methods of stimulating an immune response
09/21/2005CN1671407A Compositions and methods for treating diabetes
09/21/2005CN1671399A Myocardial perfusion imaging using A2A receptor agonists
09/21/2005CN1671397A Use of alkyl phosphocholines in combination with antitumor medicaments
09/21/2005CN1671392A Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
09/21/2005CN1671391A Novel methods and compositions for alleviating pain
09/21/2005CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
09/21/2005CN1671384A Methods of treating microbial infections in humans and animals
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1671376A Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent
09/21/2005CN1671371A Combination of an aromatase inhibitor with a bisphosphonate
09/21/2005CN1671370A Composition for solubilization of paclitaxel and preparation method thereof
09/21/2005CN1671367A Aqueous 2, 6-diisopropylphenol pharmaceutical compositions
09/21/2005CN1671365A Improved transdermal delivery system
09/21/2005CN1671351A NSAID-containing topical formulations that demonstrate chemopreventive activity
09/21/2005CN1669573A Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparing process thereof
09/21/2005CN1669554A Liposome vitality conazole preparation
09/21/2005CN1220060C Process for screening active component from plant extract
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/21/2005CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
09/20/2005US6947845 Method of identifying molecules that bind to the large ribosomal subunit
09/20/2005US6947844 Modulators of ribosomal function and identification thereof
09/20/2005US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/20/2005US6946490 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
09/20/2005US6946484 Controlling cancer by reducing its growth and improving response to therapy
09/20/2005US6946476 For therapy of metabolic and eating disorders such as obesity and hyperphagia, diabetes
09/20/2005US6946456 Administering compounds which inhibit heat shock protein 90 proteins; methods block Rb negative or deficient cells in the G2/M phase of the cell cycle and rapidly causes their destruction
09/20/2005US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance
09/20/2005US6946441 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
09/20/2005US6946438 focal cerebral ischemic infarction; plasmin, mini-plasmin (lacking the first four kringles), and micro-plasmin (lacking all five kringles)
09/20/2005US6946275 Human testis specific serine/threonine kinase 1 and 2
09/20/2005US6946259 Compositions and methods for treating cells having double minute DNA
09/20/2005US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/20/2005US6946151 Therapeutic compositions
09/20/2005US6946149 Salt solution for colon cleansing
09/20/2005US6946141 As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005US6946121 Composition in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
09/20/2005US6945247 Method of treating cardio pulmonary diseases with no group compounds
09/20/2005CA2360649C Method of preparing particles for agglomeration
09/20/2005CA2348869C Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
09/20/2005CA2285119C Retroviral protease inhibiting compounds
09/20/2005CA2218549C Method to increase retinal blood flow
09/20/2005CA2113515C Inhibiting the development of tolerance to and/or dependence on an addictive substance
09/15/2005WO2005085846A1 Diagnostic for ischemic heart disease risk group
09/15/2005WO2005085421A2 Treatment of spinal conditions
09/15/2005WO2005085274A1 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients
09/15/2005WO2005085254A1 Process for inhibiting cell proliferation
09/15/2005WO2005085241A1 Thiazole derivative
09/15/2005WO2005085237A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
09/15/2005WO2005084727A1 Bone grafting material, comprising a porous carrier and at least one pyrrolindone, a method for its production and an implant
09/15/2005WO2005084710A2 Nanocell drug delivery system
09/15/2005WO2005084709A1 Remedy for urinary disorder
09/15/2005WO2005084708A1 Medicinal composition containing cxcr3 inhibitor